Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omega-3 Fatty Acid Monograph Released For Comment By CRN Working Group

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition is urging official standards-setting bodies, including the U.S. Pharmacopeia, AOAC International and the European Pharmacopoeia, to adopt a CRN working group's final monograph for omega-3 fatty acids

You may also be interested in...



IoM Omega-3 Fatty Acid DRI Recommendations Criticized By CRN

The 1Institute of Medicine's report on macronutrient Dietary Reference Intakes contains "unacceptably low" recommendations for the omega-3 fatty acids EPA and DHA, the Council for Responsible Nutrition asserts

IoM Omega-3 Fatty Acid DRI Recommendations Criticized By CRN

The 1Institute of Medicine's report on macronutrient Dietary Reference Intakes contains "unacceptably low" recommendations for the omega-3 fatty acids EPA and DHA, the Council for Responsible Nutrition asserts

IoM Omega-3 Fatty Acid DRI Recommendations Criticized By CRN

The 1Institute of Medicine's report on macronutrient Dietary Reference Intakes contains "unacceptably low" recommendations for the omega-3 fatty acids EPA and DHA, the Council for Responsible Nutrition asserts

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093795

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel